Tilray Brands Shares Rise on Rescheduling Speculation
Tilray Brands (TLRY) shares surged 10% on Thursday, driven by speculation that the Trump administration may reclassify marijuana to Schedule III, potentially unlocking federal tax benefits and expansion opportunities. The move has sparked optimism among investors, though prediction markets assign only a 39% probability of rescheduling by year-end 2026, with execution risks remaining.
Tickers: $TLRY
Topics: marijuana rescheduling regulatory change speculation stock price movement Tilray Brands